In events involving insulin reported to the Pennsylvania Patient Safety Authority, more than half led to situations
in which a patient may have or actually received the
wrong dose or no dose of insulin, which could lead to difficulties in glycemic control. Strategies to address these problems include limiting the variety of insulin products, developing standardized protocols and a standardized prescription format, avoiding the use of abbreviations, and requiring an independent double check of all doses before dispensing and administering intravenous insulin.